Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Dan Emil Lind

Repotrectinib (TPX-0005), Effectively Reduces Growth of ALK Driven Neuroblastoma Cells

Scientific Reports

Multidisciplinary

English

Related publications

OA09 Preliminary Clinical Activity of Repotrectinib (TPX-0005) in Advanced ROS1 Fusion-Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

NeuroD1 Promotes Neuroblastoma Cell Growth by Inducing the Expression of ALK

Cancer Research

English

ALK and GSK3: Shared Features of Neuroblastoma and Neural Crest Cells

Journal of Experimental Neuroscience

English

The ALK Inhibitor PF-06463922 Is Effective as a Single Agent in Neuroblastoma Driven by Expression of ALK and MYCN

DMM Disease Models and Mechanisms

Molecular Biology

English

Flotillin-1 Regulates Oncogenic Signaling in Neuroblastoma Cells by Regulating ALK Membrane Association

Cancer Research

Cancer Research

English

ALK in Neuroblastoma: Biological and Therapeutic Implications

Cancer Research

English

Aberrant Activation of ALK Kinase by a Novel Truncated Form ALK Protein in Neuroblastoma

Cancer Research

Molecular Biology

English

P565 Validation of Novel Growth-Promoting and Growth-Suppressing Genes in Neuroblastoma Cells

English